Company intelligence / Profile preview

ChemScene

Monmouth Junction, New Jersey, United Stateschemscene.com ↗

Ownership: Private
Employees: ~729
Development stage: Other

Overview

ChemScene does not conduct its own clinical trials or report clinical results. It supplies high-quality chemicals—building blocks, bioactive small molecules, peptides—for global pharmaceutical R&D. Its offerings support discovery through commercial production. No direct clinical results.

Therapeutic areas: OncologyImmunologyOther
Modalities: Small moleculePeptidesOligonucleotide (including PROTACs)Antibody-drug conjugate linker technologyScreening library compoundsBioactive moleculesBuilding blocks & intermediates
Industry: Chemicals & Materials

Partnerships

Collaborates closely with universities, research institutes and pharmaceutical/biotech companies globally as a supplier/service provider

Beyond the preview

Go deeper on ChemScene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemScene.

Explore the full profile